BMBL Forecast



Bearish   ↔   Bullish



80% Confidence




Bullish Case: Ithaca's $1.3B take-private (~$6.00) is signed and announced; at $5.99 the stock trades at deal value with a small spread to close. Market-implied density peaks hard at $6.00 (0.38) and Helium's agrees (0.36), so the path to $6.00 on deal completion dominates. Calls outtraded puts 82%, and downside strikes carry junk IV — the tail scenarios are largely arbitration/closing risk, not fundamentals.




Bearish Case: Deal risk is real: financing withdrawal, regulatory hiccups, or a shareholder vote failure re-exposes a business with eight straight revenue-decline quarters and eroding payers. The IV surface still shows elevated far-strike vols and backwardation, and the historical return surface concentrates mass in negative returns — if the deal breaks, reversion toward $2.50–3.50 (both densities' secondary mass) is fast and severe.




Potential Outcomes:
  • 55% — Deal closes at ~$6.00 by mid-2027: falsifiable if BMBL converges to and holds $6.00; both densities peak at $6.00 (0.36–0.38).
  • 20% — Deal extends but holds: regulatory/financing delay keeps price $5.70–5.95 for months; falsifiable via vote or HSR timeline slippage.
  • 10% — Deal break, gap to $2.50–3.50: falsifiable on termination notice or financing withdrawal.
  • 10% — Rival/counter-bid >$6.50: falsifiable via competing offer news; short interest and 82% call skew hint at this tail.
  • 5% — Legal/vote failure with distressed fundamentals resurfacing, <$2.50: falsifiable via covenant or restructuring disclosures.



November 19, 2026















See risk, trade-offs, and measured results before you decide.